RMD
ResMed Inc. · Healthcare · Medical - Instruments & Supplies
Señales de momentum (gestores comparables):
amplitud de titulares +13.3% ·
flujo de acciones +17.4% ·
nuevas posiciones netas +11.8%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 159 | +2 | 76.69M | $14.96B | +7 | −4 |
| Q1 2026 | 159 | +3 | 74.11M | $16.62B | +5 | −3 |
| Q4 2025 | 155 | -2 | 83.70M | $20.16B | +1 | −2 |
| Q3 2025 | 21 | 0 | 49.43M | $13.53B | — | −1 |
| Q2 2025 | 19 | +1 | 44.83M | $11.56B | +1 | — |
| Q1 2025 | 15 | -1 | 12.96M | $2.90B | — | −1 |
| Q4 2024 | 16 | -2 | 12.69M | $2.90B | — | −2 |
| Q3 2024 | 17 | +2 | 6.96M | $1.70B | +2 | — |
| Q2 2024 | 15 | — | 5.93M | $1.13B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 3.86M | +10.9% | $939.11M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 3.86M | +10.9% | $939.11M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Norges Bank ✦ (pasivo) | 479.43K | +11.0% | $117.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Coatue Management ✦ | 473.18K | Nuevo | $115.51M | 0.4% | New | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 403.47K | -0.1% | $98.50M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 403.47K | -0.1% | $98.50M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 389.20K | -10.8% | $95.01M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 308.56K | -25.4% | $75.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 308.56K | -25.4% | $75.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 267.59K | +54.9% | $65.32M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 267.59K | +54.9% | $65.32M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 267.59K | +54.9% | $65.32M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 267.59K | +54.9% | $65.32M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 229.44K | +1141.2% | $56.01M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 229.44K | +1141.2% | $56.01M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 198.18K | +795.0% | $48.38M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 93.90K | -43.5% | $22.92M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 84.00K | -61.8% | $20.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Wellington Management ✦ | 59.93K | +35.7% | $14.63M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Wellington Management ✦ | 59.93K | +35.7% | $14.63M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 46.44K | +5.1% | $11.34M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 26.73K | +6.2% | $6.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Baillie Gifford ✦ | 15.50K | -70.5% | $3.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Baillie Gifford ✦ | 15.50K | -70.5% | $3.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Baillie Gifford ✦ | 15.50K | -70.5% | $3.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 15.26K | +593.8% | $3.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Adage Capital Partners ✦ | 11.44K | Nuevo | $2.79M | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Coatue Management | $115.51M | 0.4% |
| Adage Capital Partners | $2.79M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 932 tenedores, 96.37M acciones, $21.06B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 4.99K acc. · $1.03M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología